We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Croda International plc (CRDA) ORD GBP0.10609756

Sell:3,349.00p Buy:3,352.00p 0 Change: 12.00p (0.36%)
FTSE 100:0.26%
Market closed |  Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:3,349.00p
Buy:3,352.00p
Change: 12.00p (0.36%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:3,349.00p
Buy:3,352.00p
Change: 12.00p (0.36%)
Market closed |  Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Croda International Plc is a United Kingdom-based specialty chemicals company. The Company uses its smart science to create high performance ingredients and technologies that improve people's lives. Its sales, marketing and research activities are organized into three global market sectors: consumer care, life sciences and industrial specialties. Its consumer care sector's business units comprise beauty actives, fragrances and flavors, beauty care, and home care. It a has large actives portfolio across two ranges: Sederma Actives and Croda Botanicals. The beauty care delivers differentiated ingredients across skin, hair and solar care. The Company's life sciences sector's business units comprise agriculture (crop protection and seed enhancement) and pharma. The crop protection unit offers ingredients that improve performance and delivery of crop formulations. The pharma comprises three technology platforms: protein/small molecule delivery; adjuvant systems, and nucleic acid delivery.

Contact details

Address:
Cowick Hall
GOOLE
DN14 9AA
United Kingdom
Telephone:
+44 (01405) 860551
Website:
https://www.croda.com/

Important dates

Future events
Final results 25 February 2025 25/02/25
Past events
Interim dividend payment date 08 October 2024 08/10/24
Interim ex-dividend date 05 September 2024 05/09/24
Interim results 30 July 2024 30/07/24
Final dividend payment date 29 May 2024 29/05/24
AGM 24 April 2024 24/04/24
Final ex-dividend date 18 April 2024 18/04/24
Annual report 15 March 2024 15/03/24
Final results 27 February 2024 27/02/24

General stock information

EPIC:
CRDA
ISIN:
GB00BJFFLV09
Market cap:
£4.67 billion
Shares in issue:
139.64 million
Sector:
Chemicals
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE 100,FTSE 350,FTSE All Share

Key personnel

  • Steve Foots
    Group Chief Executive, Executive Director
  • Stephen Oxley
    Chief Financial Officer, Executive Director
  • Anthony Fitzpatrick
    Interim Chief Financial Officer and President Strategy, Corporate Development and Industrial Specialties
  • Michelle Lydon
    President - Human Resources
  • Daniele Piergentili
    President - Life Sciences
  • Mark Robinson
    President - Global Operations
  • Thomas Brophy
    Group General Counsel, Company Secretary, President - Sustainability
  • Phil Ruxton
    Chief Sustainability Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.